Sandoz International GmbH

Tweet this page
<
2023
2024
>
Registration as it was on 09 Oct 2024
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

100,000€ - 199,999€

Financial year: Jan 2023 - Dec 2023

Lobbyists (Full time equivalent)

0.75 Fte (2)

Lobbyists with EP accreditation

1

High-level Commission meetings

1

Lobbying Costs over the years

  • Info

    Sandoz International GmbH

    EU Transparency Register

    111463951460-07 First registered on 12 Oct 2023

    Goals / Remit

    Our Purpose at Sandoz is clear: pioneering access for patients. Our Purpose shines through in our rich heritage, as in our plans for the future. Our Vision is to be the world’s leading and most valued generics and biosimilars company. We aim to be valued for how we run our business, but also for the positive impact we have on society. That’s how we will deliver sustainably on our Purpose.

    Main EU files targeted

    Antimicrobial Resistance, EU Pharmaceutical Legislation, EU Pharmaceutical Strategy, F-Gas Regulation, Industrial Strategy, IP Action Plan, Orphan Medicines Regulation, Pediatric Medicines, Pharmaceutical Pricing, Waste Water Treatment Directive, Critical Medicines Act, Biotech Act

    Address

    Head Office
    Industriestr. 25
    Holzkirchen 83607
    GERMANY
    EU Office
    Industriestr. 25
    Holzkirchen 83607
    GERMANY

    Website

  • People

    Total lobbyists declared

    2

    Employment timeLobbyists
    50%1
    25%1

    Lobbyists (Full time equivalent)

    0.75

    Lobbyists with EP accreditation

    All Lobbyists with EP accreditation over time

    1 accreditations were / are live (in bold) for the selected state of 14 Mar 2025

    Name Start date End Date
    Gregor Makuc 06 Nov 2024 01 Jan 2025
    Arnaud Maheas 05 Nov 2024 04 Nov 2025
    Arnaud MAHÉAS 29 Feb 2024 04 Oct 2024

    Complementary Information

    In 2024, 1 associate in Brussels spends 50% of working time on activities falling within the scope of the register.

    1 associate at Europe headquarters spends up to 25% of working time on activities falling within the scope of the register.

    Other associates involved on activities falling within the scope of the register spent less than 10% of their time on such activities.

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    Companies & groups

  • Networking

    Affiliation

    Medicines for Europe (including Biosimilar Medicines Sector Group and VAM Sector Group)
    European Healthcare Distribution Association (GIRP)
    APIC (CEFIC Sector Group)
    EPC (European Policy Center)

    Member organisations

    None declared

  • Financial Data

    Interests represented

    Promotes their own interests or the collective interests of their members

    Closed financial year

    Jan 2023 - Dec 2023

    Lobbying costs for closed financial year

    100,000€ - 199,999€

    Major contributions in closed year

    None declared

    Intermediaries for closed year

    NameAmount
    acumen public affairs 10,000€ - 24,999€
    fleishman-hillard 10,000€ - 24,999€

    Intermediaries for current year

    Name
    acumen public affairs

    Closed year Costs

    100,000€ - 199,999€

    Other financial info

    We have calculated the estimate of annual costs related to activities that occurred in 2023 after the spin-off from Novartis (October 2023-December 2023) and that are covered by the register by adding our membership fees, event costs, consultancy fees together with facilities (rental charges) and personal costs.

  • EU Structures

    Groups (European Commission)

    None declared

    Groups (European Parliament)

    N/A

    Communication activities

    None declared

    Other activities

    None declared

  • Meetings

    Meetings

    1 meetings found. Download meetings

    The list below covers meetings with Commissioners/Cabinet members/Directors-general (high-level) Commission meetings published December 2014 to December 2024, and the meetings of Commissioners/Cabinet members/Directors-general and officials holding "management functions" in the Commission published since 1 January 2025. Other lobby meetings with lower-level staff may well have taken place, but the Commission doesn't proactively publish information about these meetings. All information below comes from the Commission and not from the registrant.

    1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.

    • Date 07 Jun 2024 Location Kundl, Austria
      Subject Strategic autonomy and current developments in the medical/pharmaceutical sector
      Cabinet Cabinet of Commissioner Johannes Hahn
      Attending
      • Johannes Hahn (Commissioner)
Download this datacard